La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Cigna Group Croissance future
Future contrôle des critères 2/6
Cigna Group devrait augmenter ses bénéfices et son chiffre d'affaires de 19.5% et de 6.8% par an respectivement. Le BPA devrait croître de de 23.4% par an. Le rendement des capitaux propres devrait être 19.8% dans 3 ans.
Informations clés
19.4%
Taux de croissance des bénéfices
23.3%
Taux de croissance du BPA
Healthcare croissance des bénéfices | 19.3% |
Taux de croissance des recettes | 6.8% |
Rendement futur des capitaux propres | 19.7% |
Couverture par les analystes | Good |
Dernière mise à jour | 20 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Cigna Group: Services Focus Leads To Outperformance
Jul 29Cigna: Game Over For PBMs?
Jul 12Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet
Jun 14Cigna: Will Benefit From Lower Medicaid Enrollments
Jun 11The Cigna Group (NYSE:CI) Not Lagging Market On Growth Or Pricing
May 27Cigna: An Up-And-Coming Dividend Growth Stock To Buy Now
May 13Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture
May 09Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being
Apr 18Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why
Apr 09Returns Are Gaining Momentum At Cigna Group (NYSE:CI)
Apr 05Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018
Apr 01Cigna: Trimming The Fat And Staying Focused
Mar 05Cigna: Big Buybacks And Total Return Potential
Feb 26Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40
Feb 05Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap
Jan 29We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt
Jan 25Why Dividend Growth Investors Should Buy Cigna
Jan 18It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)
Jan 09Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital
Dec 25Cigna: Sentiment And Fundamentals On Their Side
Dec 21Cigna's Merger Fumble: A Festive Financial Rebound
Dec 11Humana And Cigna Topple On Rumors Of An Unlikely Union
Nov 30Cigna Delivering Growth At A Great Price
Nov 13Cigna: Too Cheap To Ignore
Oct 24We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt
Oct 06Cigna: Buy Rating Driven By Undervaluation & Revenue Growth
Oct 01Cigna Group (NYSE:CI) Is Reinvesting At Lower Rates Of Return
Sep 21Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape
Sep 14Cigna Group: Weaker Than Peers But Still A Buy
Aug 27Cigna: Buy During The Next Correction (Technical Analysis)
Aug 08Cigna Group (NYSE:CI) Has A Pretty Healthy Balance Sheet
Jul 02Cigna: Buy While It's Still Cheap And Not Loved
Jun 29If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity
Jun 18Cigna: Buy This Value Gem Before It Bounces Back
Jun 12Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture
Jun 04Cigna: Many Reasons To Invest
May 29An Intrinsic Calculation For The Cigna Group (NYSE:CI) Suggests It's 49% Undervalued
May 21Is Cigna Group (NYSE:CI) A Risky Investment?
Mar 24Cigna Corporation: Undervalued For Stable Growth
Feb 23Do Cigna's (NYSE:CI) Earnings Warrant Your Attention?
Feb 21Cigna (NYSE:CI) Will Pay A Larger Dividend Than Last Year At $1.23
Feb 06CIGNA Q4 2022 Earnings Preview
Feb 02Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 262,119 | 7,864 | 12,014 | 11,414 | 14 |
12/31/2025 | 246,811 | 7,146 | 10,881 | 10,846 | 19 |
12/31/2024 | 237,964 | 5,079 | 11,733 | 11,115 | 18 |
6/30/2024 | 216,008 | 3,708 | 7,960 | 9,398 | N/A |
3/31/2024 | 204,145 | 3,620 | 10,160 | 11,625 | N/A |
12/31/2023 | 195,187 | 5,164 | 10,240 | 11,813 | N/A |
9/30/2023 | 189,856 | 5,292 | 10,892 | 12,445 | N/A |
6/30/2023 | 186,031 | 6,677 | 11,414 | 12,902 | N/A |
3/31/2023 | 182,808 | 6,774 | 10,239 | 11,654 | N/A |
12/31/2022 | 180,031 | 6,704 | 7,361 | 8,656 | N/A |
9/30/2022 | 180,028 | 6,627 | 9,578 | 10,832 | N/A |
6/30/2022 | 179,185 | 5,491 | 8,402 | 9,668 | N/A |
3/31/2022 | 176,986 | 5,401 | 6,928 | 8,128 | N/A |
12/31/2021 | 174,267 | 5,370 | 6,037 | 7,191 | N/A |
9/30/2021 | 170,397 | 8,384 | 6,041 | 7,210 | N/A |
6/30/2021 | 167,028 | 8,151 | 4,915 | 5,986 | N/A |
3/31/2021 | 163,141 | 8,438 | 8,487 | 9,556 | N/A |
12/31/2020 | 160,550 | 8,458 | 9,256 | 10,350 | N/A |
9/30/2020 | 157,009 | 5,300 | 7,764 | 8,849 | N/A |
6/30/2020 | 154,629 | 5,263 | 9,339 | 10,415 | N/A |
3/31/2020 | 154,168 | 4,917 | 7,057 | 8,180 | N/A |
12/31/2019 | 153,743 | 5,104 | 8,435 | 9,485 | N/A |
9/30/2019 | 129,660 | 4,271 | 5,896 | 6,818 | N/A |
6/30/2019 | 102,510 | 3,692 | 4,176 | 4,981 | N/A |
3/31/2019 | 75,145 | 3,090 | 4,318 | 4,937 | N/A |
12/31/2018 | 48,569 | 2,637 | 3,242 | 3,770 | N/A |
9/30/2018 | 44,969 | 2,759 | 3,742 | 4,219 | N/A |
6/30/2018 | 44,001 | 2,547 | 4,333 | 4,830 | N/A |
3/31/2018 | 42,949 | 2,554 | N/A | 4,532 | N/A |
12/31/2017 | 42,043 | 2,237 | N/A | 4,086 | N/A |
9/30/2017 | 41,332 | 2,353 | N/A | 4,358 | N/A |
6/30/2017 | 40,723 | 2,249 | N/A | 5,035 | N/A |
3/31/2017 | 40,258 | 1,946 | N/A | 4,684 | N/A |
12/31/2016 | 40,007 | 1,867 | N/A | 4,026 | N/A |
9/30/2016 | 39,252 | 1,911 | N/A | 4,315 | N/A |
6/30/2016 | 38,761 | 2,002 | N/A | 3,017 | N/A |
3/31/2016 | 38,293 | 2,080 | N/A | 3,117 | N/A |
12/31/2015 | 37,876 | 2,094 | N/A | 2,933 | N/A |
9/30/2015 | 37,276 | 2,135 | N/A | 2,319 | N/A |
6/30/2015 | 36,644 | 2,122 | N/A | 2,175 | N/A |
3/31/2015 | 35,885 | 2,107 | N/A | 2,241 | N/A |
12/31/2014 | 34,914 | 2,102 | N/A | 2,158 | N/A |
9/30/2014 | 34,098 | 1,996 | N/A | 2,084 | N/A |
6/30/2014 | 33,407 | 2,015 | N/A | 2,444 | N/A |
3/31/2014 | 32,654 | 1,947 | N/A | 2,014 | N/A |
12/31/2013 | 32,380 | 1,476 | N/A | 719 | N/A |
9/30/2013 | 31,888 | 1,521 | N/A | 900 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CI ( 19.5% par an) est supérieure au taux d'épargne ( 2.5% ).
Bénéfices vs marché: Les bénéfices de CI ( 19.5% par an) devraient croître plus rapidement que le marché US ( 15.1% par an).
Croissance élevée des bénéfices: Les bénéfices de CI devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de CI ( 6.8% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de CI ( 6.8% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de CI devrait être faible dans 3 ans ( 19.8 %).